The Barchart Chart of the Day belongs to the oncology stock NovoCure (NVCR).
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.
Barchart technical indicators:
100% technical buy signals
129.90+ Weighted Alpha
100.88% gain in the last year
Trend Spotter buy signal
Above its 20, 50 and 100 day moving averages
4 new highs and up 10.12% in the last month
Relative Strength Index 71.26%
Technical support level at 38.13
Recently traded at 39.99 with a 50 day moving average of 34.50
Fundamental factors:
Market Cap $3.60 billion
Revenue expected to grow 42.00% this year and another 50.00% next year
Earnings estimated to increase 5.70% this year, an additional 124.20% next year and continue to compound at an annual rate of 60.00% for the next 5 years
Wall Street analysts issued 2 strong buy, 3 buy and 1 hold recommendation on the stock
Leave A Comment